Literature DB >> 23573354

Epstein-Barr virus associated lymphoepithelial carcinoma of the esophagus.

Tadashi Terada1.   

Abstract

Lymphoepithelial carcinoma (LEC), also called lymphoepithelioma-like carcinoma, is defined as an undifferentiated carcinoma or poorly differentiated squamous cell carcinoma, accompanied by a prominent reactive lymphoplasmacytic infiltrate. LEC can occur in many organs, but is most common in head and neck regions including pharynx. LEC may be associated with Epstein-Barr virus (EBV) infection. LEC of the esophagus is extremely rare; only nine cases have been reported. A 79-year-old man presented epigastralgia and dysphagia. A blood laboratory test showed no significant findings. He was a hepatitis C virus healthy carrier. Tumor markers of CEA and SCC were normal. Upper gastrointestinal endoscopy showed a tumor in the lower esophagus. Biopsies were taken, and they identified malignant epithelioid cells and heavy infiltration of mature lymphocytes. The epithelioid cells showed large size, nuclear atypia, mitotic figure, hyperchromasia, and increased nucleo-cytoplasmic ratio. The lymphocytes were free from atypia. Immunohistochemically, the epithelioid cells were positive for cytokeratin (CK) AE1/3, CK CAM5.2, CK WSS, CK MNF16, CK KL1, CK5/6, CK7, CK8, CK14, CK18, CK19, p53, and Ki-67 (labeling=27%). They were negative for CK34BE12, CK20, p63, CEA, CA19-9, NSE, synaptophysin, CD56, chromogranin, KIT (CD117), desmin, vimentin, MUC apomucins, and several leukocytic markers. The epithelioid cells were positive for EBV associated molecules including EBV-encoded nuclear antigen2 (EBNA2), EBV latent membrane protein-1 (LMP-1), and EBV early RNAs (EBER). The lymphocytes were positive for CD45 and vimentin, and were composed of B-cells positive for CD20, CD79α, bcl-2, and CD10, T-cells positive for CD3 and CD45RO, NK-cells positive for CD56, and plasma cells positive for CD38, CD138, CD79α, κ-chain, and λ-chain. No light chain restriction was seen. Most of the lymphocytes were B and T-cells, and NK-cells and plasma cells were very scant. The lymphoplasma cells were reactive cells, because of no atypia and also because no p53 and very low Ki-67 labeling (3%). The lymphocytes were negative for CD21 and other antigens such as CKs and EMA. The pathological diagnosis was primary LEC of the esophagus. Imaging techniques revealed lymph nodes metastasis of the perigastric and periaortic regions, but identified no other tumors in the body. The patient was inoperative, and was treated by chemoradiation. The esophageal LEC and lymph nodes metastases were markedly reduced in size.

Entities:  

Keywords:  Epstein-Barr virus; Esophagus; immunohistochemistry; lymphoepithelial carcinoma

Year:  2013        PMID: 23573354      PMCID: PMC3609699     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  35 in total

1.  Primary signet-ring cell carcinoma of the lung: a case report with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions.

Authors:  Tadashi Terada
Journal:  Pathol Oncol Res       Date:  2011-05-31       Impact factor: 3.201

3.  Signet-ring cell carcinoma of the esophagus in dermatomyositis: a case report with immunohistochemical study.

Authors:  Tadashi Terada
Journal:  J Gastrointest Cancer       Date:  2013-12

4.  Epstein-Barr virus-associated gastric carcinoma in Mexico: analysis of 135 consecutive gastrectomies in two hospitals.

Authors:  R Herrera-Goepfert; E Reyes; M Hernández-Avila; A Mohar; R Shinkura; C Fujiyama; S Akiba; Y Eizuru; Y Harada; M Tokunaga
Journal:  Mod Pathol       Date:  1999-09       Impact factor: 7.842

5.  Lymphoepithelioma-like esophageal carcinoma: report of a case.

Authors:  T Yamada; Y Tatsuzawa; S Yagi; S Fujioka; S Kitagawa; M Nakagawa; H Minato; H Kurumaya; H Matsunou
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Med Oncol       Date:  2011-11-26       Impact factor: 3.064

Review 7.  Lymphoepithelioma-like carcinoma of the skin: a report of 3 Epstein-Barr virus (EBV)-negative additional cases. Immunohistochemical study of the stroma reaction.

Authors:  S Ferlicot; F Plantier; L Rethers; A D Bui; J Wechsler
Journal:  J Cutan Pathol       Date:  2000-07       Impact factor: 1.587

8.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

9.  Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association.

Authors:  L A Cerilli; V A Holst; M S Brandwein; M H Stoler; S E Mills
Journal:  Am J Surg Pathol       Date:  2001-02       Impact factor: 6.394

10.  Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive.

Authors:  Janina Kulka; Ilona Kovalszky; Egon Svastics; Mária Berta; Tibor Füle
Journal:  Hum Pathol       Date:  2008-02       Impact factor: 3.466

View more
  11 in total

1.  Epstein-Barr virus-associated lymphoepithelial carcinoma after pediatric liver transplant.

Authors:  Adam X Sang; Aleishia Harris-Arnold; Neeraja Kambham; Olivia M Martinez; Sheri M Krams; Debra Strichartz; Carlos O Esquivel
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

2.  Lymphoepithelioma-like carcinoma of the upper urinary tract.

Authors:  Antonio Lopez-Beltran; Gladell Paner; Ana Blanca; Rodolfo Montironi; Toyonori Tsuzuki; Yoji Nagashima; Shi-Sung Chuang; Khin Than Win; Leo Madruga; Maria R Raspollini; Liang Cheng
Journal:  Virchows Arch       Date:  2017-04-28       Impact factor: 4.064

Review 3.  Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies.

Authors:  Hui Geng; Yaqi Xing; Jingbing Zhang; Kexin Cao; Meijie Ye; Geng Wang; Caixia Liu
Journal:  Arch Virol       Date:  2021-10-12       Impact factor: 2.574

4.  A case of small well-differentiated hepatocellular carcinoma with marked lymphocytic infiltrate.

Authors:  Tomohiro Iwasaki; Aki Kubota; Makoto Suzuki; Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

5.  Primary lymphoepithelioma-like carcinoma of the esophagus with metastatic lymph node and gastric cancer.

Authors:  Kosuke Narumiya; Yosuke Yagawa; Kenji Kudo; Shinsuke Maeda; Yukinori Toyoshima; Kyohei Ogawa; Sho Izumika; Kimito Harada; Masayuki Itabashi; Harushi Osugi
Journal:  Clin J Gastroenterol       Date:  2021-07-30

6.  Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China.

Authors:  Ke Sun; Shaoyan Xu; Jianfeng Wei; Bo Wang; Kwabena Gyabaah Owusu-Ansah; Weilin Wang; Jian Wu; Shusen Zheng
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

7.  Malignant Salivary Gland Tumors and Epstein-Barr Virus (EBV) Infection: A Systematic Review and Meta-Analysis

Authors:  Hamid Reza Mozaffari; Mazaher Ramezani; Alireza Janbakhsh; Masoud Sadeghi
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 8.  Human Papillomaviruses and Epstein-Barr Virus Interactions in Colorectal Cancer: A Brief Review.

Authors:  Queenie Fernandes; Ishita Gupta; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Pathogens       Date:  2020-04-20

9.  HPV Infection, but Not EBV or HHV-8 Infection, Is Associated with Salivary Gland Tumours.

Authors:  Maja Hühns; Georg Simm; Andreas Erbersdobler; Annette Zimpfer
Journal:  Biomed Res Int       Date:  2015-11-05       Impact factor: 3.411

Review 10.  The Role of Epstein-Barr Virus in Cervical Cancer: A Brief Update.

Authors:  Semir Vranic; Farhan Sachal Cyprian; Saghir Akhtar; Ala-Eddin Al Moustafa
Journal:  Front Oncol       Date:  2018-04-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.